Theranostic Nanomedicine for Malignant Gliomas.
brain tumors
diagnosis
drug delivery
targeted therapy
theranostic nanoplatform
Journal
Frontiers in bioengineering and biotechnology
ISSN: 2296-4185
Titre abrégé: Front Bioeng Biotechnol
Pays: Switzerland
ID NLM: 101632513
Informations de publication
Date de publication:
2019
2019
Historique:
received:
29
07
2019
accepted:
28
10
2019
entrez:
5
12
2019
pubmed:
5
12
2019
medline:
5
12
2019
Statut:
epublish
Résumé
Brain tumors mainly originate from glial cells and are classified as gliomas. Malignant gliomas represent an incurable disease; indeed, after surgery and chemotherapy, recurrence appears within a few months, and mortality has remained high in the last decades. This is mainly due to the heterogeneity of malignant gliomas, indicating that a single therapy is not effective for all patients. In this regard, the advent of theranostic nanomedicine, a combination of imaging and therapeutic agents, represents a strategic tool for the management of malignant brain tumors, allowing for the detection of therapies that are specific to the single patient and avoiding overdosing the non-responders. Here, recent theranostic nanomedicine approaches for glioma therapy are described.
Identifiants
pubmed: 31799246
doi: 10.3389/fbioe.2019.00325
pmc: PMC6868071
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
325Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2019 d'Angelo, Castelli, Benedetti, Antonosante, Catanesi, Dominguez-Benot, Pitari, Ippoliti and Cimini.
Références
Cell Cycle. 2012 Mar 15;11(6):1202-16
pubmed: 22391209
Cell. 1998 Oct 2;95(1):29-39
pubmed: 9778245
Mol Pharm. 2010 Dec 6;7(6):1879
pubmed: 21128687
Nanotheranostics. 2017 Mar 3;1(1):131-140
pubmed: 29071182
Cancers (Basel). 2019 Jan 18;11(1):
pubmed: 30669406
Materials (Basel). 2018 May 11;11(5):
pubmed: 29751640
Biomaterials. 2009 May;30(15):2919-28
pubmed: 19230966
Bioconjug Chem. 2011 Oct 19;22(10):1879-903
pubmed: 21830812
Adv Mater. 2012 Jul 24;24(28):3779-802
pubmed: 22610698
Nat Nanotechnol. 2007 Dec;2(12):751-60
pubmed: 18654426
J Cell Physiol. 2017 Feb;232(2):312-322
pubmed: 27171480
Biomaterials. 2012 Apr;33(11):3324-33
pubmed: 22281423
Pharmacol Res. 2017 Jan;115:87-95
pubmed: 27865762
Ther Deliv. 2013 Jun;4(6):687-704
pubmed: 23738667
Biomaterials. 2012 Jan;33(3):856-66
pubmed: 22036101
Clin Cancer Res. 2001 Feb;7(2):243-54
pubmed: 11234875
JAMA Oncol. 2017 Aug 01;3(8):1094-1101
pubmed: 28426845
Cancer Epidemiol Biomarkers Prev. 2014 Oct;23(10):1985-96
pubmed: 25053711
Nano Lett. 2004 Jan 1;4(1):11-18
pubmed: 28890669
J Control Release. 2017 Oct 28;264:102-111
pubmed: 28842313
PLoS One. 2013 Apr 30;8(4):e62425
pubmed: 23638079
Expert Rev Anticancer Ther. 2015;15(10):1233-55
pubmed: 26402250
J Mater Chem B. 2015 Apr 28;3(16):3297-3305
pubmed: 32262324
Cancer Res. 2002 Jan 1;62(1):200-7
pubmed: 11782378
J Biomed Nanotechnol. 2016 Feb;12(2):347-56
pubmed: 27305768
Nanoscale. 2015 Feb 7;7(5):1782-90
pubmed: 25519743
Mol Pharm. 2010 Dec 6;7(6):1899-912
pubmed: 20822168
Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14720-5
pubmed: 11121071
Mol Pharm. 2014 Jul 7;11(7):2346-57
pubmed: 24893333
Mol Pharm. 2014 Jul 7;11(7):1949-63
pubmed: 24641309
J Control Release. 2018 May 10;277:89-101
pubmed: 29522834
Adv Drug Deliv Rev. 2011 Aug 14;63(9):772-88
pubmed: 21554908
Semin Cancer Biol. 2009 Feb;19(1):4-11
pubmed: 19101633
Biochem Biophys Res Commun. 2015 Dec 18;468(3):419-27
pubmed: 26168726
Cancer Treat Rev. 2002 Apr;28(2):115-20
pubmed: 12297119
Curr Opin Drug Discov Devel. 2010 Jan;13(1):111-23
pubmed: 20047152
Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3749-54
pubmed: 21321221
Nat Rev Cancer. 2004 Nov;4(11):891-9
pubmed: 15516961
Clin Radiol. 2010 Jul;65(7):500-16
pubmed: 20541650
Acta Biomater. 2018 Jun;73:52-63
pubmed: 29678675
Colloids Surf B Biointerfaces. 2016 May 1;141:429-442
pubmed: 26895505
Br J Radiol. 2012 Sep;85(1017):e729-33
pubmed: 22215883
Neuro Oncol. 2016 May;18(5):691-9
pubmed: 26519740
Colloids Surf B Biointerfaces. 2011 May 1;84(1):82-7
pubmed: 21251801
J Control Release. 2015 Feb 28;200:138-57
pubmed: 25545217
Int J Mol Sci. 2018 Jun 29;19(7):
pubmed: 29966227
Mol Cancer Ther. 2006 Nov;5(11):2624-33
pubmed: 17121909
Lancet. 2003 Jan 25;361(9354):323-31
pubmed: 12559880
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4240-5
pubmed: 10200246
Stem Cells Int. 2016;2016:6809105
pubmed: 26880981
Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:32-38
pubmed: 28575990
Rev Med Liege. 2008 May-Jun;63(5-6):251-6
pubmed: 18669189
Oncogene. 2009 Nov 12;28(45):4009-21
pubmed: 19718054
Adv Drug Deliv Rev. 2006 Dec 1;58(14):1556-77
pubmed: 17107738
Adv Drug Deliv Rev. 2006 Oct 1;58(8):962-74
pubmed: 16996642
Neuropathol Appl Neurobiol. 2018 Feb;44(2):139-150
pubmed: 28815663
Int J Pharm. 2017 Oct 5;531(1):389-410
pubmed: 28801108
Mol Pharm. 2013 Mar 4;10(3):793-812
pubmed: 23294202
J Am Chem Soc. 2012 May 2;134(17):7414-22
pubmed: 22486413
Oncotarget. 2018 Jan 3;9(6):6883-6896
pubmed: 29467937
J Biomed Biotechnol. 2012;2012:672760
pubmed: 22665988
Mol Pharm. 2015 Sep 8;12(9):3250-60
pubmed: 26198693
Adv Funct Mater. 2014 Jul 16;24(27):4206-4220
pubmed: 25477774
Nat Rev Cancer. 2017 Jan;17(1):20-37
pubmed: 27834398
Theranostics. 2015 Feb 20;5(6):559-82
pubmed: 25825597
Clin Cancer Res. 2004 Nov 1;10(21):7157-62
pubmed: 15534087
Adv Drug Deliv Rev. 2015 Dec 1;95:2-14
pubmed: 26344675
J Nanosci Nanotechnol. 2015 Aug;15(8):5501-11
pubmed: 26369109
Adv Drug Deliv Rev. 2017 Jan 1;108:25-38
pubmed: 27137110
ACS Nano. 2014 Oct 28;8(10):10655-64
pubmed: 25259648
Acc Chem Res. 2011 Oct 18;44(10):1050-60
pubmed: 21919457
FASEB J. 2008 Jul;22(7):2243-52
pubmed: 18263700
J Food Drug Anal. 2014 Mar;22(1):3-17
pubmed: 24673900
Theranostics. 2018 Feb 5;8(6):1481-1493
pubmed: 29556336
Mater Sci Eng C Mater Biol Appl. 2017 May 1;74:167-176
pubmed: 28254282
Adv Drug Deliv Rev. 2018 May;130:17-38
pubmed: 30009886
J Mater Chem B. 2013 Jul 7;1(25):3128-3135
pubmed: 32260912
Chem Soc Rev. 2004 Jan 10;33(1):43-63
pubmed: 14737508
Cell. 2000 Oct 13;103(2):211-25
pubmed: 11057895
Int J Pharm. 2011 Sep 20;416(2):443-7
pubmed: 21315141
Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):2965-9
pubmed: 1557402
Nanotheranostics. 2018 Jan 1;2(1):70-86
pubmed: 29291164
Drug Resist Updat. 2011 Jun;14(3):150-63
pubmed: 21330184
Biomaterials. 2008 Feb;29(4):487-96
pubmed: 17964647
Nano Res. 2010 Oct 1;3(11):779-793
pubmed: 21804931
Drug Deliv. 2016 Jun;23(5):1788-98
pubmed: 26431064
Sci Rep. 2014 Nov 14;4:7057
pubmed: 25394758
Int J Pharm. 2015 Mar 15;481(1-2):154-61
pubmed: 25644286
Adv Drug Deliv Rev. 2010 Aug 30;62(11):1064-79
pubmed: 20691229
Drug Discov Today. 2012 Sep;17(17-18):928-34
pubmed: 22484464
Materials (Basel). 2019 May 15;12(10):
pubmed: 31096609
Neurosurg Rev. 2015 Jan;38(1):27-37; discussion 37
pubmed: 25173621
J Cereb Blood Flow Metab. 2016 May;36(5):862-90
pubmed: 26868179
Mol Pharm. 2010 Aug 2;7(4):969-83
pubmed: 20524664
J Colloid Interface Sci. 2011 Nov 1;363(1):403-9
pubmed: 21821262
Acc Chem Res. 2011 Oct 18;44(10):893-902
pubmed: 21848274
FASEB J. 2008 Dec;22(12):4179-89
pubmed: 18697838
Nanomedicine (Lond). 2010 Nov;5(9):1401-14
pubmed: 21128722
Nanoscale. 2012 Jan 21;4(2):330-42
pubmed: 22134683
Expert Rev Neurother. 2008 Oct;8(10):1457-73
pubmed: 18928341
J Control Release. 2011 Jan 20;149(2):111-6
pubmed: 20888381
ACS Nano. 2008 May;2(5):889-96
pubmed: 19206485
Oncol Rev. 2019 Jul 25;13(2):417
pubmed: 31410248
Acc Chem Res. 2011 Oct 18;44(10):1094-104
pubmed: 21812415
Colloids Surf B Biointerfaces. 2016 Nov 1;147:129-141
pubmed: 27497076
Nano Lett. 2005 Feb;5(2):331-8
pubmed: 15794621
Trends Mol Med. 2008 May;14(5):228-35
pubmed: 18403264
Chem Soc Rev. 2011 Jan;40(1):173-90
pubmed: 20877875
Neurol Sci. 2018 Dec;39(12):2021-2031
pubmed: 30327956
Biotechnol Adv. 2013 Sep-Oct;31(5):593-606
pubmed: 23111203
Biomaterials. 2011 Jan;32(2):528-37
pubmed: 20869767
Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):781-6
pubmed: 14711994
Nat Biomed Eng. 2017 Oct;1(10):796-806
pubmed: 31015588
Drug Deliv. 2016 May;23(4):1261-71
pubmed: 26961144
Acc Chem Res. 2011 Oct 18;44(10):883-92
pubmed: 21548618
Drug Deliv. 2016 May;23(4):1369-73
pubmed: 26017099
Biomaterials. 2013 Jan;34(4):1193-203
pubmed: 23168385
Int J Pharm. 2017 Jun 30;526(1-2):380-390
pubmed: 28465052
Biomaterials. 2011 Oct;32(30):7600-8
pubmed: 21745689
Nanomedicine (Lond). 2013 Oct;8(10):1601-9
pubmed: 23265347
Biomaterials. 2013 Feb;34(7):1772-80
pubmed: 23228423
Nat Rev Drug Discov. 2003 May;2(5):347-60
pubmed: 12750738
Adv Drug Deliv Rev. 2014 Feb;66:42-57
pubmed: 24060923
Adv Funct Mater. 2015 Jan 7;25(1):36-43
pubmed: 25729344
Mol Cancer Res. 2006 Dec;4(12):927-34
pubmed: 17189383
Nanomedicine. 2016 Jan;12(1):81-103
pubmed: 26370707
Pharmaceutics. 2018 Oct 09;10(4):
pubmed: 30304861
Adv Drug Deliv Rev. 2013 May;65(5):689-702
pubmed: 22921598
Cancer Res. 2007 Sep 1;67(17):8156-63
pubmed: 17804728
Acta Pharm Sin B. 2014 Jun;4(3):193-201
pubmed: 26579383
Pharm Res. 2014 Jun;31(6):1390-406
pubmed: 24595494
Adv Drug Deliv Rev. 2013 May;65(5):622-48
pubmed: 22975010
Drug Deliv. 2016 Oct;23(8):2720-2725
pubmed: 26203691
Drug Deliv. 2016 Nov;23(9):3408-3416
pubmed: 27181462
Cancer Cell. 2008 Jun;13(6):472-82
pubmed: 18538731
Cells. 2019 Aug 09;8(8):
pubmed: 31405017
J Control Release. 2015 May 28;206:49-57
pubmed: 25724273
Adv Mater. 2011 Sep 22;23(36):H217-47
pubmed: 21842473
Biomed Res Int. 2014;2014:207974
pubmed: 24971317
Colloids Surf B Biointerfaces. 2017 Apr 1;152:277-288
pubmed: 28122295
Colloids Surf B Biointerfaces. 2018 Jan 1;161:302-313
pubmed: 29096375
Nanoscale. 2015 Jun 7;7(21):9487-96
pubmed: 25909483
Stem Cell Res Ther. 2017 Mar 9;8(1):53
pubmed: 28279193
Clin Cancer Res. 2006 Dec 15;12(24):7261-70
pubmed: 17189397
Theranostics. 2014 Mar 26;4(6):660-77
pubmed: 24723986
Nanomedicine (Lond). 2014 Jul;9(9):1277-80
pubmed: 25204816
Mol Pharm. 2010 Dec 6;7(6):1921-9
pubmed: 20964352
J Korean Neurosurg Soc. 2015 May;57(5):323-8
pubmed: 26113958
Biomaterials. 2013 Apr;34(12):2969-79
pubmed: 23380351
J Control Release. 2016 Aug 10;235:34-47
pubmed: 27208862
Nanomedicine (Lond). 2011 Apr;6(3):529-44
pubmed: 21542690
Int J Pharm. 2012 Feb 28;423(2):509-15
pubmed: 22178618
Trends Biotechnol. 2011 Jul;29(7):323-32
pubmed: 21489647
Int J Pharm. 2016 Feb 29;499(1-2):10-19
pubmed: 26721730
Int J Nanomedicine. 2018 Mar 15;13:1601-1610
pubmed: 29588587
Theranostics. 2018 May 11;8(12):3284-3307
pubmed: 29930730
Oncotarget. 2017 May 18;8(40):66889-66900
pubmed: 28978003
J Control Release. 2012 Jun 10;160(2):254-63
pubmed: 22245688
Pharmacol Res. 2010 Aug;62(2):115-25
pubmed: 20097288
Cancers (Basel). 2011 Jun 10;3(2):2655-66
pubmed: 21796273